HMOs_LNnT

产品剂型	白色至类白色粉状
产品规格	纯度 > 98%
产品包装	20g、30g、50g、100g、500g、1000g/包
适用范围	婴配食品，功能食品，饮料，营养补充剂，特医食品，医药
产研规划	已量产，即将上市
分子量	707.63
化学式	C26H45O21
CAS号	13007-32-4

[1]. Andersson, B. E. N. G. T., Dahmen, J., Frejd, T., Leffler, H., Magnusson, G., Noori, G., & Eden, C. S. (1983). Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells. The Journal of experimental medicine, 158(2), 559-570.
[2].Andersson, B., Porras, O., Hanson, L. Å., Edén, C. S., & Leffler, H. (1985). Non-antibody-containing fractions of breast milk inhibit epithelial attachment of Streptococcus pneumoniae and Haemophilus influenzae. The Lancet, 325(8429), 643.
[3]. El-Hawiet, A., Kitova, E. N., & Klassen, J. S. (2015). Recognition of human milk oligosaccharides by bacterial exotoxins. Glycobiology, 25(8), 845-854.
[4]. Sela, D. A., Garrido, D., Lerno, L., Wu, S., Tan, K., Eom, H. J., ... & Mills, D. A. (2012). Bifidobacterium longum subsp. infantis ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides. Applied and environmental microbiology, 78(3), 795-803.
[5]. Ruiz-Moyano, S., Totten, S. M., Garrido, D. A., Smilowitz, J. T., German, J. B., Lebrilla, C. B., & Mills, D. A. (2013). Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve. Applied and environmental microbiology, 79(19), 6040-6049.
[6]. Duranti, S., Lugli, G. A., Milani, C., James, K., Mancabelli, L., Turroni, F., ... & Ventura, M. (2019). Bifidobacterium bifidum and the infant gut microbiota: an intriguing case of microbe‐host co‐evolution. Environmental microbiology, 21(10), 3683-3695.
[7]. Puccio, G., Alliet, P., Cajozzo, C., Janssens, E., Corsello, G., Sprenger, N., ... & Steenhout, P. (2017). Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial. Journal of Pediatric Gastroenterology and Nutrition, 64(4), 624.
[8]. Berger, B., Porta, N., Foata, F., Grathwohl, D., Delley, M., Moine, D., ... & Sprenger, N. (2020). Linking human milk oligosaccharides, infant fecal community types, and later risk to require antibiotics. MBio, 11(2), 10-1128.
[9]. Miwa, M., Horimoto, T., Kiyohara, M., Katayama, T., Kitaoka, M., Ashida, H., & Yamamoto, K. (2010). Cooperation of β-galactosidase and β-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology, 20(11), 1402-1409.
[10]. Marcobal, A., Barboza, M., Sonnenburg, E. D., Pudlo, N., Martens, E. C., Desai, P., ... & Sonnenburg, J. L. (2011). Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell host & microbe, 10(5), 507-514.
[11]. Vester Boler, B. M., Rossoni Serao, M. C., Faber, T. A., Bauer, L. L., Chow, J., Murphy, M. R., & Fahey Jr, G. C. (2013). In vitro fermentation characteristics of select nondigestible oligosaccharides by infant fecal inocula. Journal of agricultural and food chemistry, 61(9), 2109-2119.
[12]. Chia, L. W., Mank, M., Blijenberg, B., Bongers, R. S., Van Limpt, K., Wopereis, H., ... & Knol, J. (2021). Cross-feeding between Bifidobacterium infantis and Anaerostipes caccae on lactose and human milk oligosaccharides. Beneficial microbes, 12(1), 69-83.
[13]. Hester, S. N., & Donovan, S. M. (2012). Individual and combined effects of nucleotides and human milk oligosaccharides on proliferation, apoptosis and necrosis in a human fetal intestinal cell line.
[14]. Flom, J. D., & Sicherer, S. H. (2019). Epidemiology of cow’s milk allergy. Nutrients, 11(5), 1051.
[15]. Nowak-Wegrzyn, A., Czerkies, L., Reyes, K., Collins, B., & Heine, R. G. (2019). Confirmed hypoallergenicity of a novel whey-based extensively hydrolyzed infant formula containing two human milk oligosaccharides. Nutrients, 11(7), 1447.